Department of Anesthesiology and Perioperative Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
Br J Anaesth. 2022 Feb;128(2):e71-e74. doi: 10.1016/j.bja.2021.10.013. Epub 2021 Nov 15.
Massive transfusion protocols were developed to deliver blood for life-threatening haemorrhage; however, there are no guidelines to advise when massive transfusion protocols may be considered futile. Early recognition of clinical futility remains a challenge as studies have not identified variables that can accurately determine early mortality. As blood is a scarce resource, efforts to distribute it equitably to all patients who would benefit are of paramount importance. In this editorial we discuss recent data and various aspects important in developing and implementing tools that assist with determining futility in massive transfusion.
大量输血方案是为治疗危及生命的出血而制定的;然而,目前尚无指南来指导何时可以认为大量输血方案无效。由于研究尚未确定可以准确预测早期死亡率的变量,因此早期识别临床无效性仍然是一个挑战。由于血液是一种稀缺资源,因此努力将其公平地分配给所有受益的患者至关重要。在这篇社论中,我们讨论了最近的数据和在开发和实施有助于确定大量输血无效性的工具方面的各个重要方面。